Related Experiment Video
Updated: Jan 17, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Comparative evaluation of coagulation profiles across different stages of chronic kidney disease: A cross-sectional
Emelina Stambolliu1, Panagiota Giannou1, Aikaterini Damianaki1
1Nephrology Department, Hippokration General Hospital, Athens, Greece.
Insights
Chronic kidney disease (CKD) progression alters coagulation, increasing thrombosis risk even in early stages. Peritoneal dialysis patients show a more hypercoagulable state than hemodialysis patients.
Area of Science:
- Nephrology
- Hematology
- Clinical Chemistry
Background:
- Patients with chronic kidney disease (CKD), particularly end-stage renal disease (ESRD), face elevated risks of both bleeding and thrombosis.
- Understanding coagulation abnormalities in CKD is crucial for managing patient outcomes.
Purpose of the Study:
- To evaluate hemostasis parameters in patients with varying stages of CKD.
- To identify differences in coagulation processes between non-dialysis CKD, hemodialysis (HD), and peritoneal dialysis (PD) patients.
Main Methods:
- Cross-sectional study involving 148 patients across CKD stages 2-5, HD, and PD.
- Standard coagulation tests, thromboelastography (TEG), and platelet function analysis (PFA) were performed.
Main Results:
- Coagulation parameters (D-Dimers, FVIII, fibrinogen, vWF, aPTT) and TEG values progressively worsened with advancing CKD stages (p < 0.05).
- Peritoneal dialysis patients exhibited a more hypercoagulable state compared to hemodialysis patients, evidenced by differences in FVIII, vWF, PFA, and TEG.
- Estimated glomerular filtration rate (eGFR) independently predicted most coagulation and TEG parameters.
Conclusions:
- CKD progression is associated with a prothrombotic profile, detectable even in early stages.
- Significant differences in coagulation exist between HD and PD patients, with PD patients showing increased hypercoagulability.
- These findings highlight the complex hemostatic alterations in CKD and dialysis modalities.
Background And Aims:
Patients with chronic kidney disease (CKD), especially those with end stage renal disease (ESRD) are prone to both bleeding and thrombosis. We aimed to evaluate several hemostasis parameters and identify any differences in the coagulation process among patients with CKD at different stages.
Methods:
This cross-sectional study included patients with CKD stages 2 to5 (non-dialysis) and ESRD patients on hemodialysis (HD) or peritoneal dialysis (PD). Standard coagulation tests were performed, along with thromboelastography (TEG) and platelet function analyze (PFA).
Results:
A total of 148 patients were included in the analysis, mean age 65.6 ± 14.3 years; 75 % males; 76 % hypertensive. Significant differences were identified across all groups, particularly between CKD stages 2 and 5, in D-Dimers, FVIII, homocysteine, fibrinogen, von Willebrand factor (vWF), aPTT and TEG parameters (maximal amplitude [MA], K time, A angle), with values progressively increasing as CKD advanced (all p < 0.05). The PD and HD groups had major differences in FVIII, vWF, PFA and TEG parameters, with PD patients being more hypercoagulable. PFA values did not correlate with TEG parameters, while platelet count correlated with both PFA and MA values. eGFR independently predicted most of the coagulation and TEG parameters tested.
Conclusion:
CKD progression affects TEG, PFA, and most coagulation examinations, indicating a prothrombotic profile even in the early stages of CKD. Moreover, significant differences in coagulation parameters are observed between HD and PD patients, with the latter exhibiting a more pronounced hypercoagulable state. These results should be interpreted cautiously, considering the limitations and the possible confounders of the study.
More Related Videos
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury I: Introduction
Chronic Kidney Disease I: Introduction

